Experimental Ebola vaccine safe, prompts immune response

An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail